Pressure phosphene self-tonometry in a patient with Posner-Schlossman syndrome.
Leung Dexter Y L, Rao Srinivas K, Lam Dennis S C
AI Summary
This study showed pressure phosphene self-tonometry in a Posner-Schlossman patient was accurate, reliable, and reduced unscheduled clinic visits by nearly 50%, offering potential for improved home IOP monitoring.
Abstract
Studies have shown that pressure phosphene tonometry (PPT) may be applied to glaucoma patients. It has the potential for patients to self-monitor the intraocular pressure (IOP) at home. We describe the successful use of this approach in a patient with Posner-Schlossman syndrome. In the first part of the study, we investigated whether our patient could use PPT accurately and reliably. In the second part of the study, our patient performed daily home self-tonometry, and was educated to seek ophthalmic assessment if his self-measured IOP was >or=21 mmHg. The outcome measurements included IOP and the number of unscheduled attendances for ophthalmic assessment. The use of PPT reduced his number of unscheduled hospital visits from 0.82 to 0.47 visits per month. PPT can be applied with accuracy, reliability and safety in patients with Posner-Schlossman syndrome, with potential benefits in reducing unnecessary ophthalmic attendances by nearly 50%.
MeSH Terms
Shields Classification
Related Articles5
Ocular pulse amplitude as a diagnostic adjunct in giant cell arteritis.
Observational StudyBilateral Acute Iris Transillumination and Elevated Intraocular Pressure After COVID-19 Infection.
Case SeriesClinical relevance of fibrin membranous structures in the intra-photoreceptor outer segment separation on spectral domain optical coherence tomography (SD-OCT) in initial-onset acute Vogt-Koyanagi-Harada disease.
Retrospective StudiesIntraocular ointment causing uveitis and glaucoma.
Case ReportImmediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab.
Case SeriesIs this article assigned to the wrong chapter(s)? Let us know.